Corrigendum: Peroxisome proliferator–activated receptor-α: A pivotal regulator of the gastrointestinal tract

Corrigendum: Peroxisome proliferator–activated receptor-α: A pivotal regulator of the gastrointestinal tract

Bibliographic Details
Main Authors:	Yue-Xin Guo, Bo-Ya Wang, Han Gao, Rong-Xuan Hua, Lei Gao, Cheng-Wei He, Ying Wang, Jing-Dong Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Molecular Biosciences
Subjects:	gastrointestinal diseases, metabolism transcription disorder peroxisome proliferator-activate receptor gamma (PPARγ)
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2022.1063551/full

Similar Items

Peroxisome Proliferator–Activated Receptor-α: A Pivotal Regulator of the Gastrointestinal Tract
by: Yue-Xin Guo, et al.
Published: (2022-04-01)

Peroxisome proliferator-activated receptors-γ and hypertension: Lessons of the history of researches
by: M S Rasin
Published: (2013-09-01)

The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia
by: Iason Psilopatis, et al.
Published: (2023-02-01)

Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 gene on lipid profile and adipokines levels in obese subjects
by: Becer E, et al.
Published: (2017-06-01)

Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) <it>in vitro</it>
by: Dionisi Mauro, et al.
Published: (2012-05-01)

Structural Biology Inspired Development of a Series of Human Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Ligands: From Agonist to Antagonist
by: Hiroyuki Miyachi
Published: (2023-02-01)

Osteoarthritis: Role of Peroxisome Proliferator-Activated Receptors
by: Weibei Sheng, et al.
Published: (2023-08-01)

The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer
by: Iason Psilopatis, et al.
Published: (2023-05-01)

The Role of Peroxisome Proliferator-Activated Receptors in Polycystic Ovary Syndrome
by: Iason Psilopatis, et al.
Published: (2023-04-01)

Peroxisome proliferator-activated receptor gamma gene variants modify human airway and systemic responses to indoor dibutyl phthalate exposure
by: Clarus Leung, et al.
Published: (2022-09-01)

Evaluation of peroxisome proliferator-activated receptor-gamma (Ppar-γ) and metabolic dysfunction among hypertensive nigerians
by: Oloruntoba Ayodele Ekun, et al.
Published: (2021-12-01)

Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor γ Activity and on Glucose Uptake by Thiazolidinediones
by: Kyeong Won Lee, et al.
Published: (2011-08-01)

Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions
by: Lin Peng, et al.
Published: (2021-01-01)

Peroxisome proliferator-activated receptor gamma as modulator of inflammation in pulmonary sarcoidosis
by: Pejčić Tatjana, et al.
Published: (2013-01-01)

Impact of Proliferator-Activated Receptor γ Gene Polymorphisms on Risk of Schizophrenia: A Case-Control Study and Computational Analyses
by: Saman Sargazi, et al.
Published: (2020-09-01)

Curcumin promotes AApoAII amyloidosis and peroxisome proliferation in mice by activating the PPARα signaling pathway
by: Jian Dai, et al.
Published: (2021-01-01)

Peroxisome Proliferator-Activated Receptors (PPARs) and Oxidative Stress in Physiological Conditions and in Cancer
by: Giuliana Muzio, et al.
Published: (2021-10-01)

Peroxisome proliferator-activated receptor γ isoforms differentially regulate preadipocyte proliferation, apoptosis, and differentiation in chickens
by: Fang Mu, et al.
Published: (2020-12-01)

Molecular docking studies of α-mangostin, γ-mangostin, and xanthone on peroxisome proliferator-activated receptor gamma diphenyl peptidase-4 enzyme, and aldose reductase enzyme as an antidiabetic drug candidate
by: Rifa'atul Mahmudah, et al.
Published: (2021-01-01)

<i>Pparγ1</i> Facilitates ErbB2-Mammary Adenocarcinoma in Mice
by: Xuanmao Jiao, et al.
Published: (2021-04-01)

PPARγ Gene Polymorphisms, Metabolic Disorders, and Coronary Artery Disease
by: Yongyan Song, et al.
Published: (2022-03-01)

Astaxanthin as a Peroxisome Proliferator-Activated Receptor (PPAR) Modulator: Its Therapeutic Implications
by: Chang-Ik Choi
Published: (2019-04-01)

Crtc1 Deficiency Causes Obesity Potentially via Regulating PPARγ Pathway in White Adipose
by: Yimeng Hu, et al.
Published: (2021-04-01)

Investigation of peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and its effect on peroxisome proliferator-activated receptor-gamma mRNA expression in human cancer cell lines
by: Hatice Kurnaz, et al.
Published: (2019-12-01)

Protective effects of luteolin against amyloid beta-induced oxidative stress and mitochondrial impairments through peroxisome proliferator-activated receptor γ-dependent mechanism in Alzheimer's disease
by: Zhijun He, et al.
Published: (2023-10-01)

Peroxisome proliferator-activated receptors-alpha (PPAR-α) and chronic heart failure: Is there a reason to discuss the metabolic strategy of treatment?
by: I V Zhirov, et al.
Published: (2014-01-01)

PD‐1 expression affects cytokine production by ILC2 and is influenced by peroxisome proliferator‐activated receptor‐γ
by: Banu Batyrova, et al.
Published: (2020-03-01)

Whey protein powder with milk fat globule membrane attenuates Alzheimer's disease pathology in 3×Tg-AD mice by modulating neuroinflammation through the peroxisome proliferator-activated receptor γ signaling pathway
by: Yu Li, et al.
Published: (2023-08-01)

Role of peroxisome proliferator-activated receptor alpha and gamma in antiangiogenic effect of pomegranate peel extract
by: Nasim Dana, et al.
Published: (2016-01-01)

Comparing Anti-apoptotic Effects of Peroxisome Proliferator-Activated Receptor-Gamma and Angiotensin-Converting Enzyme Inhibitors using Human Umbilical Vein Endothelial Cells Exposed to Sera from Patients with Alzheimer’s Disease and Healthy Controls
by: Rokhsareh Meamar, et al.
Published: (2014-02-01)

Tissue Proteome of 2-Hydroxyacyl-CoA Lyase Deficient Mice Reveals Peroxisome Proliferation and Activation of ω-Oxidation
by: Youssef Khalil, et al.
Published: (2022-01-01)

Dexmedetomidine ameliorates hyperalgesia of rat models with neuropathic pain via upregulation of PPAR-γ
by: ZHU Feng, ZHONG Yue, DENG Yijiang, LIU Wenzhi, BIAN Jiang
Published: (2023-09-01)

Expression of peroxisome proliferator-activated receptor γ in rat retina during development
by: Ju-Ming Zhu, et al.
Published: (2015-02-01)

Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia
by: Yuina Wada, et al.
Published: (2020-12-01)

Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)
by: Fisman Enrique Z, et al.
Published: (2003-03-01)

Downregulation of peroxisome proliferator‐activated receptor gamma in the placenta correlates to hyperglycemia in offspring at young adulthood after exposure to gestational diabetes mellitus
by: Qihong Zhao, et al.
Published: (2019-03-01)

Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma
by: Hsu HT, et al.
Published: (2014-08-01)

Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
by: Yuan-Ye Qiu, et al.
Published: (2023-06-01)

Rosiglitazone (BRL49653), a PPARγ-selective agonist, causes peroxisome proliferator-like liver effects in obese mice
by: Ulrika Edvardsson, et al.
Published: (1999-07-01)

Securidaca inappendiculata-Derived Xanthones Protected Joints from Degradation in Male Rats with Collagen-Induced Arthritis by Regulating PPAR-γ Signaling
by: Zuo J, et al.
Published: (2021-02-01)